No Data
No Data
Crinetics Pharmaceuticals to Report First Quarter 2025 Financial Results on May 8, 2025
Express News | Crinetics Pharmaceuticals Announces April 2025 Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Crinetics Pharmaceuticals Announces April 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Crinetics Pharmaceuticals Says EMA Validates Marketing Authorization Application for Acromegaly Drug
Express News | Crinetics Pharmaceuticals Announces European Medicines Agency (EMA) Validation of Marketing Authorization Application (Maa) and Orphan Drug Designation (Odd) for Paltusotine in Acromegaly
J.P. Morgan Maintains Crinetics(CRNX.US) With Buy Rating, Announces Target Price $53